-
2025-521785-10-00
5
2026-03-04
Glioblastoma
-
2025-522273-10-00
3
2026-02-24
Systemic Lupus Erythematosus
-
2025-522170-36-00
5
2026-02-03
Diabetes Mellitus, Type 1
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2023-508995-12-01
4
2025-12-24
Recurrent or metastatic non-small cell lung cancer (NSCLC)
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-510778-26-00
4
2025-12-19
Metastatic Non-Small-Cell Lung Cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2024-516253-49-01
4
2025-12-12
advanced/metastatic HER2-positive breast carcinoma
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-520623-24-00
7
2025-11-19
MTAP-deleted Solid Tumors
-
2024-514695-41-00
5
2025-10-17
Ulcerative Colitis
-
2023-508804-39-00
5
2025-10-15
Ulcerative Colitis or Crohn’s Disease
-
2024-516188-10-00
6
2025-10-07
Intracerebral haemorrhage
-
2024-518645-17-00
5
2025-10-07
Blood and lymphatic diseases
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2023-508057-19-00
5
2025-09-23
Advanced HER2-expressing Biliary Tract Cancer
-
2024-520209-38-00
5
2025-09-19
Obesity or Overweight
-
2024-520107-12-00
5
2025-09-03
Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2024-517499-39-00
7
2025-07-16
Duchenne Muscular Dystrophy
-
2024-517968-36-00
5
2025-07-08
non-small cell lung cancer
-
2024-518973-32-00
5
2025-07-03
Chronic Graft-Versus-Host Disease
-
2024-511458-32-00
5
2025-06-15
Ulcerative colitis